Medicina
Facultad
University of Bordeaux
Burdeos, FranciaPublicaciones en colaboración con investigadores/as de University of Bordeaux (68)
2024
-
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer
JAMA Oncology
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
-
European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission
Journal of Clinical Oncology, Vol. 42, Núm. 16, pp. 1875-1880
-
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
Leukemia, Vol. 38, Núm. 8, pp. 1722-1730
-
High prevalence of venous thrombotic events in Cushing’s syndrome: data from ERCUSYN and details in relation to surgery
European Journal of Endocrinology, Vol. 190, Núm. 1, pp. 75-85
-
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
European Journal of Cancer, Vol. 196
-
Restrictive vs Liberal Blood Transfusions for Patients With Acute Myocardial Infarction and Anemia by Heart Failure Status: An RCT Subgroup Analysis
Canadian Journal of Cardiology, Vol. 40, Núm. 9, pp. 1705-1714
2023
-
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1370-1375
-
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 7, pp. 1376-1382
-
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study
Vaccine, Vol. 41, Núm. 1, pp. 251-262
-
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women
Annals of Oncology, Vol. 34, Núm. 4, pp. 397-409
-
Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial (Nature Medicine, (2019), 25, 11, (1706-1714), 10.1038/s41591-019-0628-7)
Nature Medicine
2022
-
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
The Journal of experimental medicine, Vol. 219, Núm. 11
-
Breaks in peristaltic integrity predict abnormal esophageal bolus clearance better than contraction vigor or residual pressure at the esophagogastric junction
Neurogastroenterology and Motility, Vol. 34, Núm. 2
-
Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial
Trials, Vol. 23, Núm. 1
-
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
European Urology, Vol. 82, Núm. 2, pp. 212-222
-
Genetic variants associated with longitudinal changes in brain structure across the lifespan
Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432
-
Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges
European Neuropsychopharmacology, Vol. 58, pp. 55-79
-
Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations
Future Virology, Vol. 17, Núm. 2, pp. 77-86